Harnessing the potential of CAR-T cell therapy: progress, challenges, and future directions in hematological and solid tumor treatments
Abstract Traditional cancer treatments use nonspecific drugs and monoclonal antibodies to target tumor cells. Chimeric antigen receptor (CAR)-T cell therapy, however, leverages the immune system's T-cells to recognize and attack tumor cells. T-cells are isolated from patients and modified to target...
Сохранить в:
| Главные авторы: | , , , , , , , , , , , , , , , , |
|---|---|
| Формат: | Artigo |
| Язык: | Inglês |
| Опубликовано: |
BMC
2023-07-01
|
| Серии: | Journal of Translational Medicine |
| Предметы: | |
| Online-ссылка: | https://doi.org/10.1186/s12967-023-04292-3 |
| Метки: |
Нет меток, Требуется 1-ая метка записи!
|
